APOA1 and metabolic syndrome: Dyslipidemia associated with obesity typically includes elevated levels of TGs, very-low-density lipoproteins (VLDL), apolipoprotein B (apoB), and non-HDL-C, combined with decreased HDL-C and apolipoprotein A-I (apoA-I).